Omnicell, Inc.
- OMCL
- NASDAQ
- Medical - Healthcare Information Services
- Pharmacy Automation
- Medication Management
$35.31
Today −0.21%Quote Oct 19, 2026, 01:54 PM UTC
+8.49%over the last month
Max drawdown −4.0%From 1-month high −4.0%3 months −21.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.61B
Quote Oct 19
Next earnings
Oct 29
Expected, not confirmed
Analyst target
$56.67
+60.5% from here
Floor
$34.98
0.9% below price
Where the price sits
19 analysts
Analyst range, low to high
$50.00$65.00
- Price $35.31
- Resistance $35.43–$35.79
- Consensus $56.67
The price is just above its floor and right under resistance. Analysts' average target sits about 60% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OMCLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $312.2M
- Connected Devices, Software Licenses, And Other$149.2M47.8%
- Hardware And Software$68.6M22.0%
- Technical Services$68.6M22.0%
- Consumables$25.8M8.3%
Industry
Medical - Healthcare Information Services
Employees
3,485
Founded
1992